My Authors
Read all threads
That relationship with Cohen isn’t the only ethical pall over Novartis. Novartis faced a number of bribery scandals. In 2017, the company faced allegations it bribed physicians and other public officials to boost prescriptions and company sales in Greece
#TrumpPressBriefing
In August 2016, Novartis executives in South Korea were indicted for allegedly making $2 million in payments to physicians in exchange for prescribing Novartis medications.
#hydroxycholoroquine
In November 2015, Novartis agreed to pay $390 million to settle a civil lawsuit related to the kickback payments to specialty pharmacy companies that distributed the drugs Exjade and Myfortic.
In the $1.2 million payment to President Donald Trump’s ex-lawyer Michael Cohen, Novartis pinned it on then-CEO Joe Jimenez and former general counsel Felix Ehrat, who had stepped down. #TrumpPressBriefing
In the recent Zolgensma data manipulation case, two top AveXis science executives, who have since been fired, were named as the culprits.
Novartis was caught up in a data manipulation crisis around its spinal muscular atrophy gene therapy Zolgensma. The actual falsification happened before Novartis acquired the drug’s developer, AveXis,
but the Swiss drugmaker decided not to alert the FDA at the critical juncture of a new drug application review. And that delay has drawn wide criticism.
Novartis, under fire for manipulating data for its gene therapy Zolgensma and for delays in alerting the FDA, has come up with a late fix that could for once put it ahead of its pharma peers, transparency-wise.
Novartis faced a series of accusations and scandals all over the world. Bribery allegations in eastern Europe and South Korea, price-fixing in Italy, data-tampering in Japan—the list goes on.
And then there's the ongoing U.S. lawsuit that claims Novartis used fake medical events to deliver kickbacks to doctors—in the form of cash, meals and personal favors—to induce them to prescribe more of the company's drugs.
Novartis has been under investigation in Korea for allegedly bribing doctors to pump up sales. Now, the Swiss drug giant is learning about its punishment in the country as authorities there decided to issue a fine of nearly $50 million.
Why isn’t the press doing more research on the drugs (and the company who makes the drugs) that Trump keeps pushing? It’s pretty obvious that he’s somehow profiting off of it.. so how does this grift work? #sandoz
#NOVARTIS #TrumpPressBriefing #hydroxychloroquine
Sandoz Inc conspired between 2013 and 2015 with other drug manufacturers and their executives to raise prices for critical medications, hurting vulnerable consumers such as the elderly.
apnews.com/9d083fa9b72292…
former senior executive of Sandoz, Hector Armando Kellum, pleaded guilty last month to conspiring with other drug company executives to fix prices and rig bids for generic drugs. Two other industry executives have pleaded guilty, and another was indicted and is awaiting trial.
Novartis AG set aside $700 million to settle a long-running lawsuit alleging the drugmaker treated U.S. doctors to lavish dinners and other events in return for boosting prescriptions.
Novartis held 80k events between 2002 and 2011 that federal prosecutors allege amounted to kickbacks masquerading as educational mtgs; fishing trips off the Florida coast, expensive meals Nobu in Manhattan, and trips to Hooters across the country.
And Sandoz sells adderol. If it’s true that Trump loves the adderol, are they the ones supplying it to him?
Novartis bribed officials and doctors in Greece..
#novartis
theguardian.com/world/2018/feb…
“The Greek parliament is to investigate 10 of the country’s top politicians over accusations they accepted bribes from the Swiss pharmaceutical firm Novartis in return for patronage that resulted in huge losses for Greece.
A confidential report by prosecutors originally tipped off by US authorities alleged that bribes of as much as €50m (£44m) were paid to politicians between 2006 to 2015 to promote Novartis’s products.
Novartis announced one of its top legal experts, who signed a $1.2m contract with Michael Cohen in February 2017, is resigning
theguardian.com/business/2018/…
Novartis was dragged into the scandal over Cohen’s payment of $130,000 to US adult film actor Stormy Daniels just days before the 2016 presidential election. #Novartis #TrumpPressBriefing
Novartis and US telecoms giant AT&T had used the services of Cohen’s firm Essential Consultants – the same company used to make the payment to Daniels.
South Korea fines Novartis $49 million over kickbacks, suspends insurance payment
reuters.com/article/us-nov…
Six former and current Novartis employees in South Korea were indicted in August last year over illegal practices to increase sales of the company’s drugs, and trials are under way.
Swiss pharmaceutical giant Novartis must face a United States government lawsuit accusing it of paying millions of dollars in kickbacks to doctors so they would prescribe its drugs, Reuters reported.
A federal judge in Manhattan ruled on Monday that the US government had offered evidence of a “company-wide kickback scheme.” It also ruled that the government does not need to prove a direct “quid pro quo” deal between medics and doctors for the company to be liable.
Novartis is accused of paying doctors kickbacks so they would prescribe drugs such as the hypertension drugs Lotrel and Valturna, as well as Starlix, which is used in the treatment of diabetes.
The lawsuit claims that those kickbacks included speaking fees for doctors at “sham” educational events. One doctor was reportedly paid to speak at his own office eight times.
Novartis allegedly treated doctors to lavish meals, including a $9,750 dinner for three at a Japanese restaurant.
American health insurance programs Medicare and Medicaid were billed millions of dollars from 2002 to 2011 for drugs prescribed by doctors who took kickbacks
In 2010, Novartis paid $422 million to settle various allegations, including claims of paying kickbacks to doctors.
Novartis agreed to pay $390 million in October 2015 to settle claims that it paid rebates to specialty pharmacies to push two of its drugs, without admitting wrongdoing.
Basel-based pharmaceutical firm Novartis paid kickbacks to a New York chemist’s in exchange for recommending refills of a blood transfusion drug it produces, according to an amended complaint filed in a civil case brought by state and federal prosecutors in New Yor
As part of its settlement with the government, BioScrip said that, beginning in 2007, Novartis told the pharmacy its refills for Exjade patients were too low and that it would lose referrals if it didn’t raise its numbers, according to court documents.
The pharmacy, using employees in an Ohio call centre, encouraged patients – some of whom had stopped using the drug – to refill their Exjade orders, according to the lawsuit, which seeks tens of millions of dollars in Medicare and Medicaid reimbursements.
In April 2013, federal prosecutors sued Novartis, accusing it of using kickbacks disguised as rebates to turn 20 or more chemist’s into a sales force for its own drug, Myfortic, which is used for kidney transplant patients.
Novartis has also been hit with a criminal complaint by Japan’s health ministry, which alleges exaggerated advertising for the heart condition and blood-pressure lowering drug Diovan.
Novartis Pharma, the company’s local unit, issued an apology on Thursday for “troubles and concerns” over the advertising, which cited clinical studies conducted in Japan that included false data.

So this is the company we’re trusting for #coronavirus ?
An employee at Swiss multinational pharmaceutical company Novartis International AG’s affiliate in China accused the drugmaker of money laundering via funding fake academic activities
Novartis, agreed to pay $25 million in 2016 to settle charges that it violated the US Foreign Corrupt Practices Act (FCPA) when its China-based subsidiaries engaged in pay-to-prescribe schemes to increase sales, according to the SEC
An anonymous whistleblower has accused Swiss drugmaker Novartis (NOVN.S) of paying bribes in Turkey through a consulting firm to secure business advantages worth an estimated $85 million,
Novartis paid Cohen for access to Trump
latimes.com/business/hiltz…
2019: Novartis waited until FDA approval to notify them them about doctored animal testing data in its Zolgensma application
Missing some Tweet in this thread? You can try to force a refresh.

Enjoying this thread?

Keep Current with OT

Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just three indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!